PCL Scaffold for Osteochondral Defect Treatment
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68407700%3A21720%2F20%3A00346717" target="_blank" >RIV/68407700:21720/20:00346717 - isvavai.cz</a>
Výsledek na webu
<a href="https://doi.org/10.4028/www.scientific.net/KEM.834.141" target="_blank" >https://doi.org/10.4028/www.scientific.net/KEM.834.141</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.4028/www.scientific.net/KEM.834.141" target="_blank" >10.4028/www.scientific.net/KEM.834.141</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
PCL Scaffold for Osteochondral Defect Treatment
Popis výsledku v původním jazyce
Osteochondral defects develop as a result of trauma, microtrauma, avascular necrosis or cancer. These are usually pre-arthrotic conditions, accompanied by chronic pain and limited joint mobility leading to decreased quality of life of the affected patients. The bone itself has self-repair potential facilitated by mesenchymal stem cells and other cells present in the bone tissue. On the other hand, mature cartilage has very low regenerative capacity due to limited mitotic potential of chondrocytes and lack of vascularization. Therefore, there is an effort to develop an alternative treatment strategy supporting and accelerating natural healing processes. We have designed nanofibrous scaffolds made of poly-ε-caprolactone/hyaluronic acid and enriched with specific growth factors - “osteogenic” part with BMP-2 and “chondrogenic” part with bFGF and TGF-β. These two parts are meant to be combined in one biphasic non-cellular scaffold which would be possible to implant in the site of injury and serve as a mechanical support for the cells. We examined proliferation and viability of cells, depth of their penetration into scaffold, cell distribution, alkaline phosphatase activity and extracellular matrix proteins expression. We showed both “osteogenic” and “chondrogenic” scaffold was suitable for cell growth. Moreover, in comparison to the control samples, these two scaffolds exhibited positive effect on chondrogenic and osteogenic differentiation, respectively.
Název v anglickém jazyce
PCL Scaffold for Osteochondral Defect Treatment
Popis výsledku anglicky
Osteochondral defects develop as a result of trauma, microtrauma, avascular necrosis or cancer. These are usually pre-arthrotic conditions, accompanied by chronic pain and limited joint mobility leading to decreased quality of life of the affected patients. The bone itself has self-repair potential facilitated by mesenchymal stem cells and other cells present in the bone tissue. On the other hand, mature cartilage has very low regenerative capacity due to limited mitotic potential of chondrocytes and lack of vascularization. Therefore, there is an effort to develop an alternative treatment strategy supporting and accelerating natural healing processes. We have designed nanofibrous scaffolds made of poly-ε-caprolactone/hyaluronic acid and enriched with specific growth factors - “osteogenic” part with BMP-2 and “chondrogenic” part with bFGF and TGF-β. These two parts are meant to be combined in one biphasic non-cellular scaffold which would be possible to implant in the site of injury and serve as a mechanical support for the cells. We examined proliferation and viability of cells, depth of their penetration into scaffold, cell distribution, alkaline phosphatase activity and extracellular matrix proteins expression. We showed both “osteogenic” and “chondrogenic” scaffold was suitable for cell growth. Moreover, in comparison to the control samples, these two scaffolds exhibited positive effect on chondrogenic and osteogenic differentiation, respectively.
Klasifikace
Druh
D - Stať ve sborníku
CEP obor
—
OECD FORD obor
30213 - Transplantation
Návaznosti výsledku
Projekt
<a href="/cs/project/NV17-32285A" target="_blank" >NV17-32285A: Funkcionalizovaná nanovlákna v prevenci vzniku kýly v jizvě</a><br>
Návaznosti
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Ostatní
Rok uplatnění
2020
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název statě ve sborníku
Key Engineering Materials Vol. 834
ISBN
9783035715194
ISSN
1013-9826
e-ISSN
—
Počet stran výsledku
7
Strana od-do
141-147
Název nakladatele
Trans Tech Publications Ltd.
Místo vydání
Pfaffikon
Místo konání akce
Salt lake city
Datum konání akce
2. 8. 2019
Typ akce podle státní příslušnosti
WRD - Celosvětová akce
Kód UT WoS článku
—